20077 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
Nanoparticulate quinazoline derivative formulations
#1802Nanoparticulate lipase inhibitor formulations
#1803Solvent-free process for preparation of hydrophilic dispersions of nanoparticles of inclusion complexes
#1804O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
#1805COMPOSITION OF AND METHOD FOR PREPARING STABLE PARTICLES IN A FROZEN AQUEOUS MATRIX
#1806COMPOSITION OF AND METHOD FOR PREPARING STABLE PARTICLES IN A FROZEN AQUEOUS MATRIX
#1807Formulations of Fenofibrate
#1808Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof
#1809Pharmaceutical Compositions of Dispersions of Drugs and Neutral Polymers
#1810Denaturants for sympathomimetic amine salts
#1811Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor
#1812Nanoparticulate bisphosphonate compositions
#1813Injectable compositions of nanoparticulate immunosuppressive compounds
#1814Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
#1815Chemoembolisation
#1816Pharmaceutical compositions of drugs and neutralized acidic polymers
#1817Aerosol and injectable formulations of nanoparticulate benzodiazepine
#1818Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
#1819External preparation for improving coital function
#1820Nanoparticulate formulations of docetaxel and analogues thereof
#1821Orally bioavailable CCI-779 formulations
#1822Impregnated powder improving bioavailability and/or solubility and method of production
#1823Drug delivery materials made by sol/gel technology
#1824Nanoparticulate candesartan formulations
#1825Stable non-crystalline formulation comprising losartan
#1826Process for the production of biodegradable, functionalised polymer particles, and use thereof as pharmaceutical supports
#1827Nanoparticulate bicalutamide formulations
#1828Nanoparticulate tacrolimus formulations
#1829Nanoparticulate benzothiophene formulations
#1830Injectable nanoparticulate olanzapine formulations
#1831Solid formulation with improved solubility and stability, and method for producing said formulation
#1832Process for producing drug ultramicroparticle and apparatus therefor
#1833Pharmaceutical formulations of celcoxib
#1834(Polyalkoxy)sulfonate surface modifiers
#1835Methods and compositions for delivery of catecholic butanes for treatment of obesity
#1836Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate
#1837Cyclosporin formulations
#1838Complexes made using low solubility drugs
#1839Pharmaceutical compositions with improved dissolution
#1840Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
#1841Submicron suspensions with polymorph control
#1842Stable dispersion of solid particles comprising a water-insoluble pyrazine compound
#1843Antiviral compositions
#1844Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof
#1845Method for formation of micro-prilled polymers
#1846Pharmaceutical compositions
#1847Nanoparticulate compositions of tubulin inhibitor compounds
#1848Method and apparatus for enhanced size reduction of particles
#1849Formulations of 1-(4-benzoyl-piperazin-1-yl)-2-[4-methoxy-7-(3-methyl-[1,2,4]triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-ethane-1,2-dione
#1850Microcrystalline cellulose compositions
#1851Pharmaceutical compositions
#1852Tablets from a poorly compressible substance
#1853Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline
#1854Amorphous pharmaceutical compositions
#1855Pharmaceutical compositions for the treatment of cancer
#1856Pharmaceutical compositions comprising a basic drug compound, a surfactant, and a physiologically tolerable water soluble acid
#1857Methods of modifying crystal habit
#1858Surfactant systems for delivery of organic compounds
#1859Class of surfactant-like materials
#1860Topical nanoparticulate spironolactone formulation
#1861Medicament composition and method of administration
#1862Solid dispersions comprising two different polymer matrixes
#1863Pharmaceutical formulation comprising (r)-bicalitamide
#1864Pharmaceutical compositions for the treatment of hyper-proliferative disorders
#1865Controlled release nanoparticle active agent formulation dosage forms and methods
#1866Pharmaceutical compositions with improved dissolution
#1867Method for producing an immediately decomposing oral form of administration which releases active ingredients
#1868Delivery system for two or more active components as part of an edible composition
#1869Antidiabetic preparation for oral administration
#1870Composite materials for controlled release of water soluble products
#1871Quaternary compounds comprising propolis as the active substance
#1872Pharmaceutical compositions of hops resins
#1873Anti tumor compositions and methods of use
#1874Tibolone-adsorbates
#1875Pharmaceutical compositions of drugs and neutralized acidic polymers
#1876Oral delivery system comprising a drug/polymer complex
#18772,4-disubstituted triazine derivatives
#1878Nanoparticulate fibrate formulations
#1879Oral delivery system
#1880Polypeptides with the capacity to entrap drugs and release them in a controlled way
#1881Carvedilol-hydrophilic solutions
#1882Solid-state form of celecoxib having enhanced bioavailability
#1883Formulation for fast dissolution of lipophilic compounds
#1884Applicatin of a bioactive agent in a solvent composition to produce a target particle morphology
#1885High pressure media milling system and process of forming particles
#1886Denaturants for sympathomimetic amine salts
#1887Salt of a sulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations
#1888Pharmaceutical nitrones
#1889Co-grinding process for the preparation of a ternary composition
#1890Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
#1891Small-particle pharmaceutical formulations of antiseizure and antidementia agents and immunosuppressive agents
#1892Nanoparticulate compositions having a peptide as a surface stabilizer
#1893Multiblock biodegradable hydrogels for drug delivery and tissue treatment
#1894One step compounding extrusion of drug filled polymers
#1895Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
#1896Process for the preparation of adsorbates of valsartan and/or its solvates or hydrates
#1897Nanoparticulate megestrol formulations
#1898Donepezil formulations
#1899Bazedoxifene acetate formulations
#1900Use of cis-Epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils
#1901Method for milling frozen microparticles
#1902Molecular dispersions of drospirenone
#1903Benzenesulfonic acid salts of clopidogrel, methods for preparing same, and pharmaceutical formulations thereof
#1904Process for the preparation of crystalline nano-particle dispersions
#1905Method of manufacturing chemical-containing composite particles
#1906Nanoparticulate therapeutic biologically active agents
#1907Method of preparation of mixed phase co-crystals with active agents
#1908Crystalline compositions for controlling blood glucose
#1909Process of forming and modifying particles and compositions produced thereby
#1910Nanoparticles for drug delivery
#1911Stabilized formulations
#1912Method for preparing submicron particle suspensions
#1913Sustained-release formulation
#1914Polyarylates for drug delivery and tissue engineering
#1915Clarithromycin formulations having improved bioavailability
#1916Process for loading and thermodynamically activating drungs on polymers by means of supercritical fluids
#1917Rosiglitazone and metformin formulations
#1918Rosiglitazone formulations
#1919Process for producing a pharmaceutical solid preparation containing a poorly soluble drug
#1920Pharmaceutical applications of hydrotropic polymer micelles
#1921Composition of insulin for nasal administration
#1922Antiaging composition
#1923Pharmaceutical compositions
#1924Pharmaceutical compositions comprising 2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo'1,5-bipyridazine in nanoparticulate form
#1925Pharmeutical microparticles
#1926Atomoxetine formulations
#1927Salts of fenofibric acid and pharmaceutical formulations thereof
#1928Release sustaining composition and sustained release preparation
#1929Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support
#1930Solid amorphous mixtures, processes for the preparation thereof and pharmaceutical compositions containing the same
#1931Method for the production and the use of microparticles and nanoparticles by constructive micronisation
#1932Test system for evaluating the compatibility of biologically active substances with copolymers
#1933Fine particle size pioglitazone
#1934Thyroid hormone analogs and methods of use
#1935Controlled release dosage forms of azithromycin
#1936Microparticles
#1937Biodegradable polyphosphoramidates for controlled release of bioactive substances
#1938Process for the preparation of free-flowing, pulverized atorvastatin adsorbates
#1939Melt blend dispersions
#1940Methods for micronization of hydrophobic drugs
#1941Novel metaxalone compositions
#1942Composition for an antifungal agent for suppressing fungal growth in an oral cavity
#1943Nicotine formulations and use thereof
#1944Partially absorbable fiber-reinforced composites for controlled drug delivery
#1945Basic drug compositions with enhanced bioavailability
#1946Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
#1947Solid pharmaceutical dosage form
#1948Novel compositions of sildenafil free base
#1949Gel stabilized nanoparticulate active agent compositions
#1950Stabilized prostaglandin formulation
#1951Implantable polymeric device for sustained release of dopamine agonist
#1952Serotonin reuptake inhibitor formulations
#1953Pharmaceutical compositions with improved dissolution
#1954Laboratory scale milling process
#1955Glipizide compositions
#1956Method for formulating healthcare products with enhanced stability
#1957Solid dispersions comprising a hygroscopic and/or deliquescent drug
#1958Nanoparticulate megestrol formulations
#1959Pharmaceutical composition for solubility enhancement of hydrophobic drugs
#1960Novel griseofulvin compositions
#1961Compositions and methods of delivery of pharmacological agents
#1962Method for the the formation of ibuprofen crystals
#1963Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment
#1964Compositions and methods for inducing ESR1, PI3K, HER2, and HER3 immune responses
#1965Mucoadhesive buccal film having a dual release carrier system
#1966Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability
#1967Fractional lobe processor
#1968Pharmaceutical composition for gastric cancer treatment and/or prevention
#1969Synthesis of hyperbranched amphiphilic polyester and theranostic nanoparticles thereof
#1970Process of thermodynamical activation of water-insoluble drugs loaded into cross-linked polymers